Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Exploring the Interplay of AHD, TB, and Cryptococcal Antigen in Nasarawa State

Domaine:

healthcare

Type de record:

paper
Créateur:
OluFolOluChi
Éditeur:
Glo
Hôte:
This study explored the existing relationships between Advanced HIV Disease (AHD), Tuberculosis (TB), and Cryptococcal Antigen (CrAg) among People Living with HIV (PLHIV) in Nasarawa State, Nigeria. This was achieved by investigating the relationship and prevalence of TB and CrAg among individuals diagnosed with AHD in Nasarawa State; and by assessing the distribution and association of demographic characteristics of the study population with TB and Cryptococcal Antigen. This study employed a cross-sectional survey design, sampling respondents across different demographics at the same time. The study sample were individuals who are currently receiving antiretroviral treatment from our healthcare facilities in Nasarawa State, Nigeria. Results showed that TB and CrAg has low prevalence among the study population, however, compared to a larger population, this will be a serious concern. The study also suggest that the demographic information of the study population had no significant relationship on the development or presence of TB or CrAg, however, the study was ableto establish that PLHIVs who had AHD were mostly women (59.8%) in the State. Recommendation were made based on the study findings and the study concluded that the existing relationships among the study variables were not impacted significantly by either age or gender of the population.

Visit

doi.org

Licenses

http://creativecommons.org/licenses/by/4.0/

Similaires

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in BotswanaCryptococcal antigen screening in Botswana, CD4 101-200Cryptococcal antigen titers and semi-quantitative assay scores among people with HIV-associated cryptococcal antigenemiaPrevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy–Experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in BotswanaEvaluation of the Initial 12 Months of a Routine Cryptococcal Antigen Screening Program in Reduction of HIV-Associated Cryptococcal Meningitis in UgandaCryptococcal antigen among HIV1-infected individuals in north-central Nigeria

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana

Background: Cryptococcal antigen (CrAg) screening for antiretroviral therapy (A

Cryptococcal antigen screening in Botswana, CD4 101-200

Extended and underlying data used to model cost-effectiveness and impact of cryptococcal antigen (Cr

Cryptococcal antigen titers and semi-quantitative assay scores among people with HIV-associated cryptococcal antigenemia

ABSTRACT While South African guideli

Prevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy–Experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in Botswana

Abstract Background Evidence to inform cryp

Evaluation of the Initial 12 Months of a Routine Cryptococcal Antigen Screening Program in Reduction of HIV-Associated Cryptococcal Meningitis in Uganda

Abstract Background: Asymptomatic Cryptococcal Antigenemia (CrAg) patients develop menin

Cryptococcal antigen among HIV1-infected individuals in north-central Nigeria

Background and Purpose: The potential for the invasion of the central nervous system by Cryptococcus